These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 10344268)

  • 1. Decreased levels of synaptosomal associated protein 25 in the brain of patients with Down syndrome and Alzheimer's disease.
    Greber S; Lubec G; Cairns N; Fountoulakis M
    Electrophoresis; 1999; 20(4-5):928-34. PubMed ID: 10344268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synaptosomal proteins, beta-soluble N-ethylmaleimide-sensitive factor attachment protein (beta-SNAP), gamma-SNAP and synaptotagmin I in brain of patients with Down syndrome and Alzheimer's disease.
    Yoo BC; Cairns N; Fountoulakis M; Lubec G
    Dement Geriatr Cogn Disord; 2001; 12(3):219-25. PubMed ID: 11244216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroendocrine-specific protein C, a marker of neuronal differentiation, is reduced in brain of patients with Down syndrome and Alzheimer's disease.
    Kim SH; Yoo BC; Broers JL; Cairns N; Lubec G
    Biochem Biophys Res Commun; 2000 Sep; 276(1):329-34. PubMed ID: 11006125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes of voltage-dependent anion-selective channel proteins VDAC1 and VDAC2 brain levels in patients with Alzheimer's disease and Down syndrome.
    Yoo BC; Fountoulakis M; Cairns N; Lubec G
    Electrophoresis; 2001 Jan; 22(1):172-9. PubMed ID: 11197169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential involvement of synaptic vesicle and presynaptic plasma membrane proteins in Alzheimer's disease.
    Shimohama S; Kamiya S; Taniguchi T; Akagawa K; Kimura J
    Biochem Biophys Res Commun; 1997 Jul; 236(2):239-42. PubMed ID: 9240416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of amyloid beta toxicity in Alzheimer's disease model Tg2576 by intraventricular antiamyloid beta antibody.
    Chauhan NB; Siegel GJ
    J Neurosci Res; 2002 Jul; 69(1):10-23. PubMed ID: 12111811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal accumulation of citrullinated proteins catalyzed by peptidylarginine deiminase in hippocampal extracts from patients with Alzheimer's disease.
    Ishigami A; Ohsawa T; Hiratsuka M; Taguchi H; Kobayashi S; Saito Y; Murayama S; Asaga H; Toda T; Kimura N; Maruyama N
    J Neurosci Res; 2005 Apr; 80(1):120-8. PubMed ID: 15704193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of molecular chaperones in brain of patients with Down syndrome.
    Yoo BC; Vlkolinsky R; Engidawork E; Cairns N; Fountoulakis M; Lubec G
    Electrophoresis; 2001 Apr; 22(6):1233-41. PubMed ID: 11358150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective loss of synaptic proteins in Alzheimer's disease: evidence for an increased severity with APOE varepsilon4.
    Tannenberg RK; Scott HL; Tannenberg AE; Dodd PR
    Neurochem Int; 2006 Dec; 49(7):631-9. PubMed ID: 16814428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant expression of signaling-related proteins 14-3-3 gamma and RACK1 in fetal Down syndrome brain (trisomy 21).
    Peyrl A; Weitzdoerfer R; Gulesserian T; Fountoulakis M; Lubec G
    Electrophoresis; 2002 Jan; 23(1):152-7. PubMed ID: 11824616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic analysis of glial fibrillary acidic protein in Alzheimer's disease and aging brain.
    Korolainen MA; Auriola S; Nyman TA; Alafuzoff I; Pirttilä T
    Neurobiol Dis; 2005 Dec; 20(3):858-70. PubMed ID: 15979880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein C-I expression in the brain in Alzheimer's disease.
    Petit-Turcotte C; Stohl SM; Beffert U; Cohn JS; Aumont N; Tremblay M; Dea D; Yang L; Poirier J; Shachter NS
    Neurobiol Dis; 2001 Dec; 8(6):953-63. PubMed ID: 11741391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SNAP-25 regulation during adrenal gland development: comparison with differentiation markers and other SNAREs.
    Hepp R; Grant NJ; Aunis D; Langley K
    J Comp Neurol; 2000 Jun; 421(4):533-42. PubMed ID: 10842212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycosylation changes in Alzheimer's disease as revealed by a proteomic approach.
    Kanninen K; Goldsteins G; Auriola S; Alafuzoff I; Koistinaho J
    Neurosci Lett; 2004 Sep; 367(2):235-40. PubMed ID: 15331161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuronal expression of GFAP in patients with Alzheimer pathology and identification of novel GFAP splice forms.
    Hol EM; Roelofs RF; Moraal E; Sonnemans MA; Sluijs JA; Proper EA; de Graan PN; Fischer DF; van Leeuwen FW
    Mol Psychiatry; 2003 Sep; 8(9):786-96. PubMed ID: 12931206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abeta localization in abnormal endosomes: association with earliest Abeta elevations in AD and Down syndrome.
    Cataldo AM; Petanceska S; Terio NB; Peterhoff CM; Durham R; Mercken M; Mehta PD; Buxbaum J; Haroutunian V; Nixon RA
    Neurobiol Aging; 2004; 25(10):1263-72. PubMed ID: 15465622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain G protein-dependent signaling pathways in Down syndrome and Alzheimer's disease.
    Lumbreras M; Baamonde C; Martínez-Cué C; Lubec G; Cairns N; Sallés J; Dierssen M; Flórez J
    Amino Acids; 2006 Nov; 31(4):449-56. PubMed ID: 16583316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amino-terminal modification and tyrosine phosphorylation of [corrected] carboxy-terminal fragments of the amyloid precursor protein in Alzheimer's disease and Down's syndrome brain.
    Russo C; Salis S; Dolcini V; Venezia V; Song XH; Teller JK; Schettini G
    Neurobiol Dis; 2001 Feb; 8(1):173-80. PubMed ID: 11162251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of Abeta11-40/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N-terminally truncated Abeta species in the pathogenesis of Alzheimer's disease.
    Liu K; Solano I; Mann D; Lemere C; Mercken M; Trojanowski JQ; Lee VM
    Acta Neuropathol; 2006 Aug; 112(2):163-74. PubMed ID: 16865398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional and progressive changes in brain expression of complexin II in a mouse transgenic for the Huntington's disease mutation.
    Freeman W; Morton AJ
    Brain Res Bull; 2004 Mar; 63(1):45-55. PubMed ID: 15121238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.